State Street Corp Genetron Holdings LTD Transaction History

State Street Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.87 - $1.04 $1,127 - $1,347	1,296 Added 3.98%	33,852 $31,000
Q1 2023 May 15, 2023	BUY	$0.91 - $1.23 $2,664 - $3,601	2,928 Added 9.88%	32,556 $34,000
Q4 2022 Feb 14, 2023	BUY	$0.8 - $1.12 $2,444 - $3,422	3,056 Added 11.5%	29,628 $33,000
Q3 2022 Nov 15, 2022	SELL	$0.91 - $1.69 $53,630 - $99,600	-58,935 Reduced 68.92%	26,572 $21,000
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.4 $76,142 - $142,766	-59,486 Reduced 41.03%	85,507 $145,000
Q1 2022 May 16, 2022	BUY	$2.19 - $6.09 $64,272 - $178,729	29,348 Added 25.38%	144,993 $318,000
Q4 2021 Feb 14, 2022	SELL	$5.81 - $14.39 $222,743 - $551,683	-38,338 Reduced 24.9%	115,645 $705,000
Q3 2021 Nov 15, 2021	BUY	$11.55 - $20.3 $968,848 - $1.7 Million	83,883 Added 119.66%	153,983 $2.13 Million
Q2 2021 Aug 16, 2021	BUY	$17.9 - $23.29 $499,409 - $649,791	27,900 Added 66.11%	70,100 $1.41 Million
Q1 2021 May 17, 2021	BUY	$13.71 - $30.64 $578,562 - $1.29 Million	42,200 New	42,200 $906,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.